Zoetis releases new Dexdomitor concentration designed for smaller dogs, cats.
Zoetis has announced a lower concentration of Dexdomitor (dexmedetomidine), a sedative and preanesthetic drug for dogs and cats. The 0.1 mg/ml dosage is designed to make it more convenient for veterinarians to accurately administer doses for dogs less than 20 pounds and cats less than 7 pounds, company representatives say.
Smaller patients require smaller volumes of Dexdomitor, which can be challenging to measure accurately. Dexdomitor 0.1 is one-fifth the original concentration, so dose volumes can be more accurately measured without the need for dilution, Zoetis says. Sedation and preanesthesia protocols can therefore be tailored to individual patients, helping to ensure consistent and predictable outcomes. The new concentration has been used in Europe since August 2013. For more information visit target="_blank" www.precisionsedation.com.
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More